SPY445.87+3.37 0.76%
DIA352.85+3.84 1.10%
IXIC14,897.34+73.91 0.50%

UBS Downgrades Amedisys to Sell Rating from Neutral, Adjusts Price Target to $150 from $261

MT Newswires · 09/24/2021 07:54

Please log in to view news